CuraVac Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

CuraVac General Information

Description

Developer of therapeutic vaccines designed to treat autoimmune diseases. The company develops vaccines to cure sclerosis, diabetes, rheumatoid arthritis and systemic lupus erythematosus, enabling patients by providing treatment and potential cure for myasthenia gravis, a debilitating autoimmune disease.

Contact Information

Website
www.curavac.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Avenue de Villefranche 80
  • 1330 Rixensart
  • Belgium
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Avenue de Villefranche 80
  • 1330 Rixensart
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CuraVac Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Generating Revenue
5. Grant 01-Nov-2019 Completed Generating Revenue
4. Angel (individual) 21-Jun-2016 Cancelled Generating Revenue
3. Accelerator/Incubator 01-Jan-2014 Completed Generating Revenue
2. Grant $9M $2.4M Completed Generating Revenue
1. Angel (individual) 01-Jan-2008 $2.4M $2.4M Completed Generating Revenue
To view CuraVac’s complete valuation and funding history, request access »

CuraVac Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic vaccines designed to treat autoimmune diseases. The company develops vaccines to cure sclerosis
Drug Discovery
Rixensart, Belgium
6 As of 2024

Basel, Switzerland

Cambridge, MA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CuraVac Competitors (56)

One of CuraVac’s 56 competitors is Baliopharm, a Venture Capital-Backed company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Baliopharm Venture Capital-Backed Basel, Switzerland
AnTolRx Formerly VC-backed Cambridge, MA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Xenikos Venture Capital-Backed Nijmegen, Netherlands
Prevail Therapeutics Formerly VC-backed New York, NY
You’re viewing 5 of 56 competitors. Get the full list »

CuraVac Patents

CuraVac Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4297775-A1 Carrier protein for peptide antigen Pending 26-Feb-2021
US-20240148863-A1 Carrier protein for peptide antigen Pending 26-Feb-2021
WO-2022180263-A1 Carrier protein for peptide antigen Inactive 26-Feb-2021
EP-4298224-A2 Method for producing a periplasmic form of the protein crm197 Pending 26-Feb-2021
US-20250326804-A1 Method for producing a periplasmic form of the protein crm197 Inactive 26-Feb-2021 C07K14/34
To view CuraVac’s complete patent history, request access »

CuraVac Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CuraVac Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
European Commission Government
To view CuraVac’s complete investors history, request access »

CuraVac FAQs

  • When was CuraVac founded?

    CuraVac was founded in 2002.

  • Where is CuraVac headquartered?

    CuraVac is headquartered in Rixensart, Belgium.

  • What is the size of CuraVac?

    CuraVac has 6 total employees.

  • What industry is CuraVac in?

    CuraVac’s primary industry is Drug Discovery.

  • Is CuraVac a private or public company?

    CuraVac is a Private company.

  • What is CuraVac’s current revenue?

    The current revenue for CuraVac is .

  • How much funding has CuraVac raised over time?

    CuraVac has raised $2.4M.

  • Who are CuraVac’s investors?

    and European Commission have invested in CuraVac.

  • Who are CuraVac’s competitors?

    Baliopharm, AnTolRx, Inovio Pharmaceuticals, Xenikos, and Prevail Therapeutics are some of the 56 competitors of CuraVac.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process